Analyze Diet
The Veterinary clinics of North America. Equine practice2017; 33(3); 465-481; doi: 10.1016/j.cveq.2017.07.003

Medical and Surgical Management of Equine Recurrent Uveitis.

Abstract: Equine recurrent uveitis (ERU) is characterized by recurrent bouts of inflammation interrupted by periods of quiescence that vary in duration. There is little consensus on the clinical manifestations, the underlying causes, or the management. The 3 commonly recognized syndromes of ERU (classic, insidious, and posterior) do not accurately separate the clinical manifestations of disease into distinct categories. An accurate diagnosis and early intervention are essential to minimizing the effects of disease and preserving vision. There are multiple medical and surgical options for controlling ERU as long as the disease is recognized early and targeted treatment is initiated immediately.
Publication Date: 2017-10-03 PubMed ID: 28985983DOI: 10.1016/j.cveq.2017.07.003Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on the medical and surgical treatments available for managing Equine recurrent uveitis (ERU), a complex eye condition in horses that involves repeated waves of inflammation, emphasizing the importance of early diagnosis and immediate treatment for preserving vision.

Understanding Equine Recurrent Uveitis (ERU)

  • The paper focuses on Equine recurrent uveitis, a condition characterized by multiple occurrences of inflammation in the horse’s eye. These inflammatory bouts are typically separated by periods of inactivity, although the duration of these quiet periods varies.
  • There is little agreement among experts regarding the clinical manifestations of the disease, its precise causes, or even its management. The research highlights that the three recognized syndromes of ERU – classic, insidious, and posterior – do not adequately differentiate the clinical signs of the disease into distinct categories.

The Importance of Diagnosis & Early Intervention

  • The paper underscores the vital role of early diagnosis and intervention for combating ERU effectively. These steps are crucial in minimizing the damaging impacts of the disease and in safeguarding the horse’s vision.
  • An accurate diagnosis is critical as it lays the groundwork for targeted and immediate treatment, essential in managing this condition. By swiftly pinpointing and tackling the disease, we can have control over it, reducing the severity and frequency of its flare-ups.

Medical & Surgical Management of ERU

  • The authors discuss multiple options for medical and surgical interventions for managing ERU. However, they stress the importance that such treatments are most effective when the disease is identified early.
  • While the article does not detail the specific pharmaceutical or surgical strategies, it suggests that these treatment modalities can effectively control ERU, reduce its impact, and retain vision. The decision of which method to utilize likely depends on the individual circumstances of each case, including the disease’s severity, the horse’s overall health status, and the resources available.

Cite This Article

APA
McMullen RJ, Fischer BM. (2017). Medical and Surgical Management of Equine Recurrent Uveitis. Vet Clin North Am Equine Pract, 33(3), 465-481. https://doi.org/10.1016/j.cveq.2017.07.003

Publication

ISSN: 1558-4224
NlmUniqueID: 8511904
Country: United States
Language: English
Volume: 33
Issue: 3
Pages: 465-481

Researcher Affiliations

McMullen, Richard Joseph
  • Department of Clinical Sciences, Auburn University, Auburn University College of Veterinary Medicine, JT Vaughan Large Animal Teaching Hospital, 1500 Wire Road, Auburn, AL 36849-5540, USA. Electronic address: rjm0040@auburn.edu.
Fischer, Britta Maria
  • Large Animal Internal Medicine, Auburn University, Auburn University College of Veterinary Medicine, JT Vaughan Large Animal Teaching Hospital, 1500 Wire Road, Auburn, AL 36849-5540, USA.

MeSH Terms

  • Animals
  • Chronic Disease
  • Horse Diseases / surgery
  • Horse Diseases / therapy
  • Horses
  • Recurrence
  • Uveitis / surgery
  • Uveitis / therapy
  • Uveitis / veterinary

Citations

This article has been cited 15 times.
  1. Kirmse L, Thieme K, Doherr MG, Eule JC. Evaluation of Laboratory Techniques for the Diagnosis of Leptospira-Associated Equine Recurrent Uveitis (ERU) With Focus on the Goldmann-Witmer Coefficient. Vet Ophthalmol 2026 Jan;29(1):e70132.
    doi: 10.1111/vop.70132pubmed: 41518147google scholar: lookup
  2. Sprenzel CJ, Amann B, Deeg CA, Degroote RL. Glycan Signatures on Neutrophils in an Equine Model for Autoimmune Uveitis. Biomolecules 2025 Oct 12;15(10).
    doi: 10.3390/biom15101444pubmed: 41154673google scholar: lookup
  3. Söth R, Hoffmann ALC, Deeg CA. Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4(+) T Cells of an Autoimmune Uveitis Model. Int J Mol Sci 2024 Oct 26;25(21).
    doi: 10.3390/ijms252111513pubmed: 39519064google scholar: lookup
  4. Kalinovskiy A, Leser S, Ehrle A, Reese S, Jones S, Gerhards H. Phacoemulsification Combined with Pars Plana Vitrectomy: Outcome in Horses with Acquired Cataracts Associated with Uveitis. Animals (Basel) 2024 Apr 16;14(8).
    doi: 10.3390/ani14081192pubmed: 38672339google scholar: lookup
  5. Morén S, Kallberg M, Strom L. Equine uveitis: Outcome and adverse effects after one or two intravitreal low-dose gentamicin injections. Equine Vet J 2025 Jan;57(1):160-168.
    doi: 10.1111/evj.14056pubmed: 38329024google scholar: lookup
  6. Degroote RL, Schmalen A, Hauck SM, Deeg CA. Unveiling Differential Responses of Granulocytes to Distinct Immunostimulants with Implications in Autoimmune Uveitis. Biomedicines 2023 Dec 20;12(1).
    doi: 10.3390/biomedicines12010019pubmed: 38275380google scholar: lookup
  7. Padjasek M, Cisło-Sankowska A, Lis-Bartos A, Qasem B, Marycz K. PLDLA/TPU Matrix Enriched with Cyclosporine A as a Therapeutic Platform for Immune-Mediated Keratitis (IMMK) in Horses. Int J Mol Sci 2023 Mar 17;24(6).
    doi: 10.3390/ijms24065735pubmed: 36982806google scholar: lookup
  8. Padjasek M, Qasem B, Cisło-Pakuluk A, Marycz K. Cyclosporine A Delivery Platform for Veterinary Ophthalmology-A New Concept for Advanced Ophthalmology. Biomolecules 2022 Oct 20;12(10).
    doi: 10.3390/biom12101525pubmed: 36291734google scholar: lookup
  9. Ekstrand C, Michanek P, Gehring R, Sundell A, Källse A, Hedeland M, Ström L. Plasma atropine concentrations associated with decreased intestinal motility in horses. Front Vet Sci 2022;9:951300.
    doi: 10.3389/fvets.2022.951300pubmed: 36118347google scholar: lookup
  10. Hasan N, Chawla R, Shaikh N, Kandasamy S, Azad SV, Sundar MD. A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology. Ther Adv Ophthalmol 2022 Jan-Dec;14:25158414221097418.
    doi: 10.1177/25158414221097418pubmed: 35602659google scholar: lookup
  11. Hermans H, van den Berg EMH, Slenter IJM, Vendrig DJC, de Nijs-Tjon LJL, Vernooij JCM, Brommer H, Boevé MH, Gehring R. Penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into the normal equine ocular fluids. Equine Vet J 2022 Sep;54(5):965-972.
    doi: 10.1111/evj.13526pubmed: 34706129google scholar: lookup
  12. Degroote RL, Deeg CA. Immunological Insights in Equine Recurrent Uveitis. Front Immunol 2020;11:609855.
    doi: 10.3389/fimmu.2020.609855pubmed: 33488614google scholar: lookup
  13. Blohm KO, Tichy A, Nell B. Clinical utility, dose determination, and safety of ocular contrast-enhanced ultrasonography in horses: A pilot study. Vet Ophthalmol 2020 Mar;23(2):331-340.
    doi: 10.1111/vop.12730pubmed: 31799804google scholar: lookup
  14. Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro. Vet Ophthalmol 2020 Jan;23(1):160-170.
    doi: 10.1111/vop.12704pubmed: 31441218google scholar: lookup
  15. Fischer BM, McMullen RJ Jr, Reese S, Brehm W. Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results. BMC Vet Res 2019 Jan 16;15(1):29.
    doi: 10.1186/s12917-018-1722-7pubmed: 30651102google scholar: lookup